Actively Recruiting

Phase Not Applicable
Age: 55Years - 85Years
MALE
ID06500169

Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors Undergoing Hormone Therapy (GREENS)

Led by University of Southern California · Updated on 2026-06-03

20

Participants Needed

2

Research Sites

52 weeks

Total Duration

On this page

Sponsors

U

University of Southern California

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a golf recreational exercise program to improve survivorship for underrepresented prostate cancer survivors, particularly those undergoing hormone therapy like androgen deprivation therapy. The study aims to explore how this golf program affects physical function, cognitive health, psychosocial wellness, and overall quality of life, as these areas can be impacted by prostate cancer treatments. Participants join a 10-week golf training program with group sessions twice a week lasting 1 to 2 hours each. The program includes warm-up exercises with pelvic floor muscle training, golf lessons with a PGA professional, golf practice, and play on a Par 3 public golf course. Participants also wear an activity tracker and provide blood samples. After completing the program, participants are followed up at 6 months. Throughout the study, researchers assess enrollment rates, adherence to the program, safety, quality of life scores, physical fitness tests, gait speed, balance confidence, cognitive function, inflammatory biomarker levels, and participant feedback. The study monitors participants up to 3 years and includes questionnaires, interviews, physical exams, and performance testing to understand the program's impact.

CONDITIONS

Brief Title

Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors

Who Can Participate

Age: 55Years - 85Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • First time, primary diagnosis of prostate cancer
  • Currently receiving androgen deprivation therapy and/or androgen receptor blocker for more than 6 months
  • Male aged 55 to 85 years
  • Ability to stand independently without external support
  • No or minimal golf experience (played less than 5 times in the past 10 years)
  • English speaking
Not Eligible

You will not qualify if you...

  • Second cancer diagnosis (excluding non-invasive skin cancers) or bone metastases
  • Prostatectomy less than 6 months prior to enrollment
  • Symptomatic cardiovascular disease, active angina, uncontrolled hypertension (SBP > 160 or DBP > 90), or high resting heart rate (> 90)
  • Symptomatic orthostatic hypotension
  • Unstable asthma or worsened chronic obstructive pulmonary disease
  • History of injury or orthopedic surgery within the last 6 months
  • Movement disorders such as Parkinson's disease or other neurological conditions, hemiparesis or paraparesis
  • Severe vision or hearing problems

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

screening and enrollment visit

Treatment

Duration - 10 weeks

Participants take part in a golf training program with group sessions led by a PGA professional including warm-up exercises, pelvic floor muscle training, golf instruction, practice, and play on a Par 3 public golf course. They also wear an activity tracker and undergo blood sample collection during this period.

Two sessions per week

Follow-up

Duration - 6 months

Participants are followed up to assess long-term effects after completing the golf training program.

1 follow-up visit

Trial Site Locations

Total: 2 locations

1

Los Angeles General Medical Center

Los Angeles, California, United States, 90033

Actively Recruiting

2

USC / Norris Comprehensive Cancer Center

Los Angeles, California, United States, 90033

Actively Recruiting

Loading map...

Research Team

G

Garry Cai

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Similar Trials

24 Gy in One Fraction Urethral-sparing High-Dose-Rate Like S...

Localized Prostate Carcinoma

Actively Recruiting

1 location

A Pragmatic Phase II Study Evaluating Tolerability in Prosta...

Advanced Prostate Adenocarcinoma

Actively Recruiting

1 location

Safe Omission of Pelvic Lymph Node Dissection During Radical...

Localized Prostate Carcinoma

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here